Ammonia Solution, Strong

Ammonia Solution, Strong

SCHEMBL27874537

Brc1cnc2[nH]cc(I)c2c1.N

nearest known ligand 0.57

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DYRK1A Q13627 7/20 0.57
JAK2 O60674 4/20 0.57
CDK5 Q00535 4/20 0.57
AURKA O14965 3/20 0.57
MAP4K4 O95819 3/20 0.57
FGFR1 P11362 3/20 0.57
FLT1 P17948 3/20 0.57
KDR P35968 3/20 0.57
CLK2 P49760 3/20 0.57
MAP4K2 Q12851 3/20 0.57
AURKB Q96GD4 3/20 0.57
CLK4 Q9HAZ1 3/20 0.57
PRKD3 O94806 2/20 0.57
TAOK1 Q7L7X3 2/20 0.57
IGF1R P08069 2/20 0.57
JAK3 P52333 2/20 0.57
LIMK1 P53667 2/20 0.57
NTRK2 Q16620 2/20 0.57
PLK4 O00444 1/20 0.57
ROCK2 O75116 1/20 0.57

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL68662 0.98 DYRK1A (0.58) DYRK1AJAK2CDK5AURKAMAP4K4
SCHEMBL15241762 0.79 BRD4 (0.49) DYRK1AJAK2CDK5AURKAMAP4K4
Valine SCHEMBL18860660 0.78 DYRK1A (0.44) DYRK1AJAK2CDK5AURKAMAP4K4
Ammonia Solution, Strong SCHEMBL27890807 0.78 JAK2 (0.57) JAK2FLT1KDRAURKBFLT3
SCHEMBL1880862 0.76 BRD4 (0.47) DYRK1AMAP4K4CLK2CLK4ROCK2
SCHEMBL1564760 0.76 ITK (0.54) DYRK1AJAK2CDK5AURKAMAP4K4
SCHEMBL1053943 0.76 JAK2 (0.58) JAK2FLT1KDRAURKBFLT3
SCHEMBL11968454 0.76 BRD4 (0.47) DYRK1AJAK2CDK5AURKAMAP4K4
SCHEMBL11968456 0.76 DYRK1A (0.54) DYRK1AJAK2CDK5AURKAMAP4K4
SCHEMBL1045946 0.76 BRD4 (0.54) DYRK1AJAK2CDK5AURKAMAP4K4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-102695417-A Compounds and methods for kinase modulation and indications therefor PLEXXIKON INC 2012-09-26 CN disclosed